BCL2L11 and neoplasm: AS-tDR-007872 was recognized as a diagnostic biomarker and a tumor suppressor for NSCLC with inhibitory effect on tumor cell proliferation, invasion, and migration, which is probably induced by targeting BCL2L11 [143].